[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:low-tension-glaucoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":43,"states":44},"Low tension glaucoma",5,1,[8,16,23,30,36],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07354477","Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation",[12],"Phase 2","RECRUITING","2026-08-26T02:16:10.529598Z","2026-05-05T02:43:26.684329Z",{"nct_id":17,"title":18,"phases":19,"status":20,"updated_at":21,"content_modified":22},"NCT07300852","DSLT in Normal Tension Glaucoma (NTG) Asian Eyes",[],"NOT_YET_RECRUITING","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:29.184400Z",{"nct_id":24,"title":25,"phases":26,"status":20,"updated_at":28,"content_modified":29},"NCT07619482","Topical Insulin for Glaucoma (TING2)",[27],"Phase 1\u002FPhase 2","2026-08-26T02:18:01.700186Z","2026-06-04T01:30:07.904073Z",{"nct_id":31,"title":32,"phases":33,"status":20,"updated_at":34,"content_modified":35},"NCT06023927","Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness",[],"2026-08-26T02:16:55.892527Z","2026-05-13T02:55:06.402528Z",{"nct_id":37,"title":38,"phases":39,"status":40,"updated_at":41,"content_modified":42},"NCT00338065","External Influences Upon Ocular Homeostasis",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:30.961790Z","2026-06-16T05:54:07.943415Z",[],[45],{"state":46,"count":47,"slug":48},"California",3,"california"]